GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $8.60 $10.98 Thursday, 18th Apr 2024 ZYME stock ended at $8.67. This is 2.03% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.78% from a day low at $8.60 to a day high of $8.93.
90 days $8.60 $13.14
52 weeks $6.02 $13.14

Historical Zymeworks Inc prices

Date Open High Low Close Volume
2024-04-18 $8.79 $8.93 $8.60 $8.67 385 351
2024-04-17 $8.96 $9.20 $8.82 $8.85 352 048
2024-04-16 $8.98 $9.09 $8.91 $8.93 247 620
2024-04-15 $9.20 $9.34 $8.97 $9.09 327 857
2024-04-12 $9.33 $9.39 $9.08 $9.25 313 732
2024-04-11 $9.18 $9.42 $9.16 $9.36 241 162
2024-04-10 $9.08 $9.19 $8.99 $9.09 538 523
2024-04-09 $9.60 $9.65 $9.11 $9.36 647 954
2024-04-08 $9.68 $9.88 $9.52 $9.62 286 005
2024-04-05 $9.66 $9.94 $9.50 $9.65 250 141
2024-04-04 $9.67 $9.98 $9.42 $9.66 470 850
2024-04-03 $9.20 $9.67 $9.20 $9.63 449 138
2024-04-02 $9.69 $9.72 $9.11 $9.23 615 520
2024-04-01 $10.47 $10.47 $9.58 $9.88 744 321
2024-03-28 $10.35 $10.57 $10.34 $10.52 440 419
2024-03-27 $10.51 $10.59 $10.30 $10.30 386 580
2024-03-26 $10.48 $10.61 $10.44 $10.47 337 767
2024-03-25 $10.51 $10.55 $10.29 $10.40 257 879
2024-03-22 $10.67 $10.67 $10.48 $10.52 243 730
2024-03-21 $10.83 $10.98 $10.59 $10.65 282 634
2024-03-20 $10.56 $10.88 $10.34 $10.75 398 758
2024-03-19 $10.61 $10.77 $10.51 $10.53 984 343
2024-03-18 $10.80 $10.90 $10.45 $10.71 383 880
2024-03-15 $10.73 $10.90 $10.62 $10.81 557 520
2024-03-14 $10.73 $11.03 $10.64 $10.77 432 367
Click to get the best stock tips daily for free!

About Zymeworks Inc

Zymeworks Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 ... ZYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT